AIP
SGYP

Ameritas Investment Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Ameritas Investment Partners’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,906
Closed -$2K – 2995
2018
Q4 		$2K Hold
19,906
– – ﹤0.01% 2974
2018
Q3 		$34K Hold
19,906
– – ﹤0.01% 2213
2018
Q2 		$35K Hold
19,906
– – ﹤0.01% 2213
2018
Q1 		$36K Hold
19,906
– – ﹤0.01% 2107
2017
Q4 		$44K Hold
19,906
– – ﹤0.01% 2002
2017
Q3 		$59K Hold
19,906
– – ﹤0.01% 1787
2017
Q2 		$89K Buy
19,906
+2,839
+17% +$11.7K ﹤0.01% 1532
2017
Q1 		$80K Buy
17,067
+1,400
+9% +$8.12K ﹤0.01% 1557
2016
Q4 		$95K Hold
15,667
– – ﹤0.01% 1083
2016
Q3 		$86K Buy
15,667
+1,530
+11% +$7.16K ﹤0.01% 1075
2016
Q2 		$54K Buy
+14,137
New +$47.9K ﹤0.01% 1031

Other funds holding SGYP

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Ameritas Investment Partners's SGYP Position: Q1 2019 in Review

Ameritas Investment Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 19,906 shares — an estimated $2K sold.

Ameritas Investment Partners first reported a position in SGYP in Q2 2016 and held it in 11 quarters. The position peaked at $95K in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • Ameritas Investment Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Partners sold 19,906 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $2K.
  • Ameritas Investment Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 11 quarters.
  • Ameritas Investment Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $95K in Q4 2016.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Ameritas Investment Partners's 13F filing for Q1 2019, filed 15 May 2019.